Cyclopharm Reports A$25.9 Million Nine-Month Revenue
Cyclopharm reported group revenue of A$25.9 million for the nine-month period.
Related stories
DHI FY2026 profit falls 19.41%
DHI reported FY2026 profit attributable to shareholders of 28.89亿美元, down 19.41% year over year. Basic EPS was 10.14美元.
M impact | EARNINGS | Oct 30, 2026, 05:41 AM UTC
Starbucks sees higher profit ahead amid turnaround progress
Starbucks expects higher profit, citing progress in its turnaround.
M impact | EARNINGS | Oct 30, 2026, 05:25 AM UTC
Sensex Edges Higher on Tech Stocks
India’s BSE Sensex edged up about 0.2% to 74,319 on Friday, extending gains from the previous session as buying in IT stocks and optimism over corporate earnings helped offset pres
H impact | EARNINGS | Oct 30, 2026, 04:53 AM UTC
BYD Electronic Reports Higher Revenue, Lower Profit for First Three Quarters
BYD Electronic reported revenue growth but a decline in net profit for the first three quarters.
M impact | EARNINGS | Oct 30, 2026, 04:49 AM UTC
Horizon Industrial Parks Revenue Rises 30% to ₹215 Crore
Horizon Industrial Parks reported a 30% year-on-year revenue increase to ₹215 crore for the quarter ended September, driven by record quarterly leasing of 2.5 million sq ft.
H impact | EARNINGS | Oct 30, 2026, 04:18 AM UTC
Nova System Reports Nine-Month Parent Recurring Profit
Parent recurring profit rose 149.3%; the company forecasts 2026 profit up 81.6%.
L impact | EARNINGS | Oct 30, 2026, 04:03 AM UTC